methamphetamine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (10.26) | 18.7374 |
1990's | 12 (30.77) | 18.2507 |
2000's | 20 (51.28) | 29.6817 |
2010's | 3 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X | 1 |
Heikkila, RE; Nicklas, WJ; Sonsalla, PK | 1 |
Heikkila, RE; Sonsalla, PK | 1 |
DeLanney, LE; Forno, LS; Irwin, I; Langston, E; Langston, JW; Ricaurte, GA | 1 |
Jarvis, MF; Wagner, GC | 1 |
Bassi, L; Corsini, GU; Fornai, F; Scalori, V; Torracca, MT | 1 |
Budai, G; Kardos, V; Pátfalusi, M; Patthy, M; Sziráki, I | 1 |
Albers, DS; Sonsalla, PK; Zeevalk, GD | 1 |
Hall, ED; Jochnowitz, ND; Oostveen, JA; Sonsalla, PK; Zeevalk, GD | 1 |
Ali, SF; Itzhak, Y; Martin, JL; Norenberg, MD | 1 |
Corsini, GU; Fornai, F; Maggio, R; Racagni, G; Riva, M; Vaglini, F | 1 |
Albers, DS; Moy, LY; Sonsalla, PK | 1 |
Ali, SF; Laws, SC; Miller, DB; O'Callaghan, JP | 1 |
Green, S; Jakowec, MW; Petzinger, GM; Tolwani, RJ; Waggie, K | 1 |
Hastings, TG; LaVoie, MJ | 1 |
Ali, SF; Black, MD; Itzhak, Y; Martin, JL | 1 |
Chancy, CD; Ganapathy, V; Huang, W; Kekuda, R; Rajan, PD; Smith, SB | 1 |
Bing, G; Jhoo, W; Kim, H; Shin, E | 1 |
Hogan, KA; Sonsalla, PK; Staal, RG | 1 |
Benkovic, S; Gordon, MN; Miller, D; O'Callaghan, JP; Pennypacker, KR; Yang, X | 1 |
Cadet, JL | 1 |
Dryhurst, G | 1 |
Battaglia, G; Busceti, CL; Fornai, F; Gesi, M; Lenzi, P; Nicoletti, F; Orzi, F; Rampello, L; Ruggieri, S; Soldani, P | 1 |
Kita, T; Konishi, N; Matsunari, Y; Nakamura, M; Nakashima, T; O'Hara, K; Saraya, T; Shimada, K; Wagner, GC | 1 |
Battaglia, G; Busceti, CL; De Blasi, A; Fornai, F; Lembo, G; Nicoletti, F | 1 |
Halász, AS; Magyar, K; Pálfi, M; Szöko, E; Tábi, T | 2 |
Binienda, Z; Gaetani, F; Virmani, A | 1 |
Miller, DB; O'Callaghan, JP; Sriram, K | 2 |
Brown, JM; Cox, BM; Gouty, S; Iyer, V; Rosenberger, J | 1 |
Bandettini Di Poggio, A; De Blasi, A; Fornai, F; Lazzeri, G; Nicoletti, F; Paparelli, A; Ruggieri, S; Soldani, P | 1 |
Ali, SF; Lyn-Cook, B; Robinson, B; Tareke, E | 1 |
Fornai, F; Paparelli, A; Pasquali, L; Ruffoli, R; Ruggieri, S; Soldani, P | 1 |
Fornai, F; Kastsiuchenka, O; Natale, G; Paparelli, A; Pasquali, L; Ruggieri, S | 1 |
Bourque, M; Di Paolo, T; Dluzen, DE | 1 |
Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; Quiñones-Hinojosa, A; Shah, A | 1 |
Dagda, RK; Das Banerjee, T; Janda, E | 1 |
Angoa-Pérez, M; Anneken, JH; Kuhn, DM | 1 |
7 review(s) available for methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Experimental models of Parkinson's disease: insights from many models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reserpine | 1999 |
Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methamphetamine; Mice; Mice, Knockout; Mice, Transgenic; Neurotoxins; Oxidopamine; Parkinsonian Disorders | 2001 |
Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; Dopamine; Dopamine Uptake Inhibitors; Glutathione; Humans; Methamphetamine; Nervous System; Neurodegenerative Diseases; Norepinephrine; Protein Precursors; Reperfusion Injury; Serotonin | 2001 |
Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites; Antioxidants; Carnitine; Central Nervous System Stimulants; Coenzymes; Energy Metabolism; Fatty Acids, Unsaturated; Glucose; Humans; Methamphetamine; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Ubiquinone | 2005 |
Neuroprotective actions of sex steroids in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Dopamine Agents; Estrogens; Humans; Methamphetamine; Mitogen-Activated Protein Kinases; Neural Pathways; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Progesterone; Receptors, Estrogen; Sex Characteristics; Signal Transduction; Steroids | 2009 |
Animal models of neurological disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents | 2010 |
How Parkinsonian toxins dysregulate the autophagy machinery.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Autophagy; Humans; Methamphetamine; Mitophagy; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinsonian Disorders; Rotenone | 2013 |
32 other study(ies) available for methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium | 1999 |
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Corpus Striatum; Dibenzocycloheptenes; Dizocilpine Maleate; Dopamine; Ketamine; Methamphetamine; Mice; Neurotoxins; Phencyclidine; Pyridines; Substantia Nigra; Tyrosine 3-Monooxygenase | 1989 |
Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neurotoxins; Pyridines; Species Specificity | 1988 |
Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Degeneration; Pyridines; Substantia Nigra | 1987 |
Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Female; Male; Methamphetamine; Pargyline; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Species Specificity | 1985 |
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Frontal Lobe; Locus Coeruleus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Serotonin; Time Factors | 1995 |
Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons | 1994 |
Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Energy Metabolism; Male; Malonates; Methamphetamine; Mice; Neostriatum; Nerve Endings; Tyrosine 3-Monooxygenase | 1996 |
Treatment of mice with methamphetamine produces cell loss in the substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Corpus Striatum; Dopamine; Dopamine Agents; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Substantia Nigra; Tyrosine 3-Monooxygenase | 1996 |
Depletion of striatal dopamine transporter does not affect psychostimulant-induced locomotor activity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Central Nervous System Stimulants; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kinetics; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Motor Activity; Neostriatum; Nerve Tissue Proteins; Protein Binding | 1997 |
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Dopamine Uptake Inhibitors; Fibroblast Growth Factor 2; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neuroprotective Agents; Neurotoxins; Nicotine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase | 1997 |
Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Methamphetamine; Mice; MPTP Poisoning; Nerve Degeneration; Neurons; Neurotoxins; Serotonin Receptor Agonists; Tyrosine 3-Monooxygenase | 1998 |
The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Corpus Striatum; Dopamine; Estradiol; Female; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Organ Size; Ovariectomy; Sex Characteristics; Uterus | 1998 |
Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alcohol Dehydrogenase; Antioxidants; Apoptosis; Catalase; Chromatography, High Pressure Liquid; Dopamine; Hydrogen-Ion Concentration; Methamphetamine; Monophenol Monooxygenase; Nerve Tissue Proteins; Neurons; Nitrates; Nitric Oxide; Nitrites; Oxidants; Oxidation-Reduction; Parkinson Disease; Protein Binding; Sulfhydryl Compounds; Superoxide Dismutase | 1999 |
Neuroprotective role of melatonin in methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Fever; Free Radical Scavengers; Melatonin; Methamphetamine; Mice; Neuroprotective Agents | 1999 |
Expression of the extraneuronal monoamine transporter in RPE and neural retina.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Biogenic Monoamines; Blotting, Northern; Carrier Proteins; Cells, Cultured; Eye; Female; Gene Expression; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Kinetics; Methamphetamine; Mice; Mice, Inbred ICR; Nicotine; Organic Cation Transport Proteins; Pigment Epithelium of Eye; Procainamide; Retina; RNA, Messenger; Steroids; Tetraethylammonium; Time Factors | 2000 |
Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Diet; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Selenium; Substantia Nigra; Tyrosine 3-Monooxygenase | 2000 |
Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Histological Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neuropeptides; Synaptic Vesicles; Synaptosomes; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- and trimethyltin-induced brain injury.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; DNA-Binding Proteins; Dopamine Agents; Fos-Related Antigen-2; Immunohistochemistry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Time Factors; Transcription Factors; Trimethyltin Compounds | 2000 |
Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Body Temperature; Catecholamines; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Immunohistochemistry; Kinetics; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Serotonin; Tyrosine 3-Monooxygenase | 2002 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Glial Fibrillary Acidic Protein; Hypothermia; Immunohistochemistry; Injections, Subcutaneous; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Time Factors; Tyrosine 3-Monooxygenase | 2003 |
Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Cytoprotection; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gliosis; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Knockout; Microdialysis; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Prazosin; Receptors, Adrenergic, alpha-1; Tyrosine 3-Monooxygenase | 2003 |
Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin or methamphetamine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Central Nervous System Stimulants; Dopamine Agents; Hippocampus; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Neostriatum; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Peroxynitrous Acid | 2004 |
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Count; Chemokine CCL2; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interleukin-6; Male; Methamphetamine; Mice; Mice, Mutant Strains; Microglia; Minocycline; Neurons; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Gene Deletion; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Knockout; Neurons; Protein Precursors; Receptors, Opioid; Reverse Transcriptase Polymerase Chain Reaction; Sex Characteristics | 2006 |
[Change of the nitric oxide synthase activity after administration of neurotoxic compounds in mice].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Citrulline; Corpus Striatum; Hippocampus; Methamphetamine; Mice; Mice, Inbred Strains; NADP; Neurotoxins; Nitric Oxide Synthase | 2006 |
Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Methamphetamine; Neurotoxins; Parkinsonian Disorders; PC12 Cells; Proteasome Endopeptidase Complex; Rats; Substantia Nigra; Ubiquitin | 2006 |
Acrylamide: a dietary carcinogen formed in vivo?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acrylamide; Animals; Carcinogens; Diet; Ferrous Compounds; Food Analysis; Food Handling; Globins; Hemoglobins; Hot Temperature; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Valine | 2008 |
Defining "neuroinflammation".
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Bacterial Agents; Antibodies, Phospho-Specific; Brain; Chemokines; Cytokines; Dopamine; Glial Fibrillary Acidic Protein; Gliosis; Humans; Inflammation; Methamphetamine; Mice; Mice, Inbred C57BL; Minocycline; Neurotoxins; NF-kappa B; Receptors, Tumor Necrosis Factor; Signal Transduction; Tyrosine 3-Monooxygenase | 2008 |
Methamphetamine fails to alter the noradrenergic integrity of the heart.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Denervation; Dopamine Agonists; Heart; Humans; Hypotension, Orthostatic; Levodopa; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurotoxins; Norepinephrine; Parkinson Disease | 2008 |
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catecholamines; Dopamine Agents; Gastrointestinal Tract; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Parkinson Disease, Secondary; Random Allocation | 2008 |
3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzodioxoles; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Female; Glial Fibrillary Acidic Protein; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Endings; Neurotoxins; Psychotropic Drugs; Pyrrolidines; Synthetic Cathinone; Tyrosine 3-Monooxygenase | 2015 |